Saltarelli M D, Yamada K, Coyle J T
Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
J Neurosci. 1990 Jan;10(1):62-72. doi: 10.1523/JNEUROSCI.10-01-00062.1990.
The involvement of phospholipase A2 (PLA2) and fatty acid release in the regulation of sodium-dependent high-affinity choline uptake in rat brain was assessed in vitro through the use of the specific binding of 3H-hemicholinium-3 (3H-HCh-3). Addition of arachidonic acid and other unsaturated fatty acids to rat striatal membranes in vitro resulted in a dose-dependent, temperature-independent activation of 3H-HCh-3 binding. Scatchard analysis revealed that these changes in binding result from a 2-fold increase in the affinity and capacity of 3H-HCh-3 binding. Saturated fatty acids, lysophospholipids, and phospholipids did not affect specific 3H-HCh-3 binding. Addition of defatted BSA to membranes, which had been treated previously with arachidonic acid, completely reversed the increase in specific 3H-HCh-3 binding. However, several inhibitors of fatty acid metabolism, including nordihydroguaiaretic acid, indomethacin, catalase, and superoxide dismutase, did not alter arachidonic acid-induced changes in 3H-HCh-3 binding, suggesting that unsaturated fatty acids, and not their metabolites, are directly responsible for the observed activation of specific 3H-HCh-3 binding. Additionally, unsaturated fatty acids dose-dependently inhibited high-affinity 3H-choline uptake in rat striatal synaptosomes, apparently due to the disruption of synaptosomal integrity. The phospholipase A2 inhibitors quinacrine hydrochloride, trifluoperazine, and 4-bromophenacylbromide dose-dependently inhibited potassium depolarization-induced activation of specific 3H-HCh-3 binding in slices of rat brain in vitro. Similarly, both quinacrine and trifluoperazine inhibited the metabolism of phospholipids and the release of fatty acids evoked by either elevated KCl or calcium ionophore A23187. These results support the involvement of PLA2 and subsequent fatty acid release in the increase of 3H-HCh-3 binding in cholinergic neurons and suggest that activation of PLA2 may be the penultimate step in regulating the velocity of sodium-dependent choline transport.
通过使用³H-半胆碱-3(³H-HCh-3)的特异性结合,在体外评估了磷脂酶A2(PLA2)和脂肪酸释放参与大鼠脑内钠依赖性高亲和力胆碱摄取调节的情况。体外向大鼠纹状体膜中添加花生四烯酸和其他不饱和脂肪酸,导致³H-HCh-3结合呈剂量依赖性、温度非依赖性激活。Scatchard分析表明,这些结合变化是由于³H-HCh-3结合的亲和力和容量增加了2倍。饱和脂肪酸、溶血磷脂和磷脂不影响³H-HCh-3的特异性结合。向先前用花生四烯酸处理过的膜中添加脱脂牛血清白蛋白(BSA),可完全逆转³H-HCh-3特异性结合的增加。然而,几种脂肪酸代谢抑制剂,包括去甲二氢愈创木酸、吲哚美辛、过氧化氢酶和超氧化物歧化酶,并未改变花生四烯酸诱导的³H-HCh-3结合变化,这表明不饱和脂肪酸而非其代谢产物直接导致了观察到的³H-HCh-3特异性结合激活。此外,不饱和脂肪酸剂量依赖性地抑制大鼠纹状体突触体中高亲和力³H-胆碱摄取,显然是由于突触体完整性的破坏。磷脂酶A2抑制剂盐酸奎纳克林、三氟拉嗪和4-溴苯甲酰溴剂量依赖性地抑制体外大鼠脑片中钾去极化诱导的³H-HCh-3特异性结合激活。同样,奎纳克林和三氟拉嗪均抑制磷脂代谢以及由高钾或钙离子载体A23187诱发的脂肪酸释放。这些结果支持PLA2及随后的脂肪酸释放在胆碱能神经元中³H-HCh-3结合增加中的作用,并表明PLA2的激活可能是调节钠依赖性胆碱转运速度的倒数第二步。